Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 06:35 am Purchase |
2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal Participations S.a r.l | 138,956 6.400% |
48,077 (+52.90%) |
Filing History |
| 2022-02-09 09:31 am Purchase |
2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
MFN Partners, LP | 169,461 7.800% |
169,461 (New Position) |
Filing History |
| 2022-02-09 09:11 am Sale |
2022-02-08 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 130,871 6.042% |
-5,115 (-3.76%) |
Filing History |
| 2021-06-07 5:21 pm Purchase |
2021-06-03 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 179,833 8.600% |
41,159 (+29.68%) |
Filing History |
| 2021-05-14 4:56 pm Purchase |
2021-05-04 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 138,675 7.800% |
138,675 (New Position) |
Filing History |
| 2021-02-12 8:55 pm Sale |
2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal Participations S.a r.l | 90,879 5.400% |
-2,200 (-2.36%) |
Filing History |
| 2021-02-12 5:09 pm Purchase |
2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
MFN Partners, LP | 121,384 7.150% |
46,990 (+63.16%) |
Filing History |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Cyclerion Therapeutics, Inc. CYCN |
FMR CORP | 135,986 8.008% |
9,412 (+7.44%) |
Filing History |
| 2021-02-05 11:24 am Unchanged |
2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
American Endowment Foundation | 133,027 7.800% |
0 (Unchanged) |
Filing History |
| 2020-09-09 3:52 pm Sale |
2020-08-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
BLACKROCK INC BLK |
79,095 4.700% |
-1,739 (-2.15%) |
Filing History |
| 2020-08-10 4:16 pm Purchase |
2020-07-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 309,803 18.300% |
309,803 (New Position) |
Filing History |